Cerebral hyperemia, stroke, and transfusion in sickle cell disease

I. Prohovnik, S. G. Pavlakis, S. Piomelli, J. Bello, J. P. Mohr, S. Hilal, D. C. De Vivo

Research output: Contribution to journalArticlepeer-review

124 Scopus citations


To investigate cerebral hemodynamics in sickle cell disease (SCD), we used the 133Xenon inhalation technique of quantifying cerebral blood flow (CBF) in 67 patients. Clinical examinations and cerebral magnetic resonance imaging also were performed in all patients. Compared with age-matched healthy controls, CBF was elevated by 68% in patients, and inversely related to hematocrit. An experimental index of cerebral blood volume, pr4, was also elevated in the patients in a similar manner. Cerebral blood volume was positively correlated to CBF in SCD patients but not in controls. History of stroke and current neurologic symptoms were associated with lower flow and higher cerebral blood volume. Transfusion therapy reduced the hyperemia, the reduction being greater than expected by hematocrit elevation alone. These findings document a vasodilatory hyperemia in SCD. This dilatation may be a risk factor for ischemic distal-field infarctions, as visualized by MRI, due to a limitation of cerebrovascular reserve capacity.

Original languageEnglish (US)
Pages (from-to)344-348
Number of pages5
Issue number3
StatePublished - Mar 1989
Externally publishedYes

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Cerebral hyperemia, stroke, and transfusion in sickle cell disease'. Together they form a unique fingerprint.

Cite this